Eric J Chow1, K Scott Baker, Stephanie J Lee, Mary E D Flowers, Kara L Cushing-Haugen, Yoshihiro Inamoto, Nandita Khera, Wendy M Leisenring, Karen L Syrjala, Paul J Martin. 1. Eric J. Chow, K. Scott Baker, Stephanie J. Lee, Mary E.D. Flowers, Kara L. Cushing-Haugen, Yoshihiro Inamoto, Wendy M. Leisenring, Karen L. Syrjala, and Paul J. Martin, Fred Hutchinson Cancer Research Center; Eric J. Chow, K. Scott Baker, Seattle Children's Hospital; Eric J. Chow, K. Scott Baker, Stephanie J. Lee, Mary E.D. Flowers, and Paul J. Martin, University of Washington, Seattle, WA; and Nandita Khera, Mayo Clinic, Phoenix, AZ.
Abstract
PURPOSE: To determine the influence of modifiable lifestyle factors on the risk of cardiovascular disease after hematopoietic cell transplantation (HCT). PATIENTS AND METHODS: HCT survivors of ≥ 1 year treated from 1970 to 2010 (n = 3,833) were surveyed from 2010 to 2011 on current cardiovascular health and related lifestyle factors (smoking, diet, recreational physical activity). Responses (n = 2,362) were compared with those from a matched general population sample (National Health and Nutrition Examination Survey [NHANES]; n = 1,192). RESULTS: Compared with NHANES participants, HCT survivors (median age, 55.9 years; median 10.8 years since HCT; 71.3% allogeneic) had higher rates of cardiomyopathy (4.0% v 2.6%), stroke (4.8% v 3.3%), dyslipidemia (33.9% v 22.3%), and diabetes (14.3% v 11.7%; P < .05 for all comparisons). Prevalence of hypertension was similar (27.9% v 30.0%), and survivors were less likely to have ischemic heart disease (6.1% v 8.9%; P < .01). Among HCT survivors, hypertension, dyslipidemia, and diabetes were independent risk factors for ischemic heart disease and cardiomyopathy, and smoking was associated with ischemic heart disease and diabetes (odds ratios [ORs], 1.8 to 2.1; P = .02). Obesity was a risk factor for post-transplantation hypertension, dyslipidemia, and diabetes (ORs ≥ 2.0; P < .001). In contrast, lower fruit/vegetable intake was associated with greater risk of dyslipidemia and diabetes (ORs, 1.4 to 1.8; P ≤ .01), and lower physical activity level was associated with greater risk of hypertension and diabetes (ORs, 1.4 to 1.5; P < .05). Healthier lifestyle characteristics among HCT survivors attenuated risk of all cardiovascular conditions assessed. CONCLUSION: Attention of clinicians to conventional cardiovascular risk factors and modifiable lifestyle characteristics offers hope of reducing serious cardiovascular morbidity after HCT.
PURPOSE: To determine the influence of modifiable lifestyle factors on the risk of cardiovascular disease after hematopoietic cell transplantation (HCT). PATIENTS AND METHODS: HCT survivors of ≥ 1 year treated from 1970 to 2010 (n = 3,833) were surveyed from 2010 to 2011 on current cardiovascular health and related lifestyle factors (smoking, diet, recreational physical activity). Responses (n = 2,362) were compared with those from a matched general population sample (National Health and Nutrition Examination Survey [NHANES]; n = 1,192). RESULTS: Compared with NHANES participants, HCT survivors (median age, 55.9 years; median 10.8 years since HCT; 71.3% allogeneic) had higher rates of cardiomyopathy (4.0% v 2.6%), stroke (4.8% v 3.3%), dyslipidemia (33.9% v 22.3%), and diabetes (14.3% v 11.7%; P < .05 for all comparisons). Prevalence of hypertension was similar (27.9% v 30.0%), and survivors were less likely to have ischemic heart disease (6.1% v 8.9%; P < .01). Among HCT survivors, hypertension, dyslipidemia, and diabetes were independent risk factors for ischemic heart disease and cardiomyopathy, and smoking was associated with ischemic heart disease and diabetes (odds ratios [ORs], 1.8 to 2.1; P = .02). Obesity was a risk factor for post-transplantation hypertension, dyslipidemia, and diabetes (ORs ≥ 2.0; P < .001). In contrast, lower fruit/vegetable intake was associated with greater risk of dyslipidemia and diabetes (ORs, 1.4 to 1.8; P ≤ .01), and lower physical activity level was associated with greater risk of hypertension and diabetes (ORs, 1.4 to 1.5; P < .05). Healthier lifestyle characteristics among HCT survivors attenuated risk of all cardiovascular conditions assessed. CONCLUSION: Attention of clinicians to conventional cardiovascular risk factors and modifiable lifestyle characteristics offers hope of reducing serious cardiovascular morbidity after HCT.
Authors: Cornelio Uderzo; Marta Pillon; Gloria Tridello; Giorgio Dini; Christian Urban; Paola Corti; Felix Zintl; Franca Fagioli; Chiara Messina; Amparo Verdeguer; Maura Faraci; Sara Fedeli; Francesco Tana; André Tichelli; Jakob Passweg; Attilio Rovelli Journal: Pediatr Transplant Date: 2008-09-26
Authors: Leslie L Robison; Gregory T Armstrong; John D Boice; Eric J Chow; Stella M Davies; Sarah S Donaldson; Daniel M Green; Sue Hammond; Anna T Meadows; Ann C Mertens; John J Mulvihill; Paul C Nathan; Joseph P Neglia; Roger J Packer; Preetha Rajaraman; Charles A Sklar; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer Journal: J Clin Oncol Date: 2009-04-13 Impact factor: 44.544
Authors: Heidi Michels Blanck; Cathleen Gillespie; Joel E Kimmons; Jennifer D Seymour; Mary K Serdula Journal: Prev Chronic Dis Date: 2008-03-15 Impact factor: 2.830
Authors: N Kawashima; Y Inamoto; T Sato; M Nakashima; Y Kagaya; K Watakabe; A Seto; N Fukushima; S Kurahashi; Y Ozawa; K Miyamura Journal: Bone Marrow Transplant Date: 2016-02-15 Impact factor: 5.483
Authors: Kasey J Leger; K Scott Baker; Kara L Cushing-Haugen; Mary E D Flowers; Wendy M Leisenring; Paul J Martin; Jason A Mendoza; Kerryn W Reding; Karen L Syrjala; Stephanie J Lee; Eric J Chow Journal: Cancer Date: 2018-01-09 Impact factor: 6.860
Authors: Danielle Novetsky Friedman; Patrick Hilden; Chaya S Moskowitz; Maya Suzuki; Farid Boulad; Nancy A Kernan; Suzanne L Wolden; Kevin C Oeffinger; Charles A Sklar Journal: Biol Blood Marrow Transplant Date: 2016-12-28 Impact factor: 5.742
Authors: Eric J Chow; Kenneth Wong; Stephanie J Lee; Kara L Cushing-Haugen; Mary E D Flowers; Debra L Friedman; Wendy M Leisenring; Paul J Martin; Beth A Mueller; K Scott Baker Journal: Biol Blood Marrow Transplant Date: 2014-02-22 Impact factor: 5.742
Authors: Nick Beije; Jurjen Versluis; Jaco Kraan; Jan W Gratama; Stefan Sleijfer; Jan J Cornelissen Journal: Haematologica Date: 2015-02-20 Impact factor: 9.941
Authors: Gregory T Armstrong; Vijaya M Joshi; Kirsten K Ness; Thomas H Marwick; Nan Zhang; DeoKumar Srivastava; Brian P Griffin; Richard A Grimm; James Thomas; Dermot Phelan; Patrick Collier; Kevin R Krull; Daniel A Mulrooney; Daniel M Green; Melissa M Hudson; Leslie L Robison; Juan Carlos Plana Journal: J Am Coll Cardiol Date: 2015-06-16 Impact factor: 24.094
Authors: Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala Journal: Biol Blood Marrow Transplant Date: 2016-09-19 Impact factor: 5.742